Advocacy

Advocacy News

ASAM and HSAM send letter to Hawaii Senator in support of SB868 to clarify regulations governing buprenorphine prescribing

February 13, 2017

PDF

 

ASAM and the Hawaii Society of Addiction Medicine (HSAM) sent a letter to Senator Ronald D. Kouchi, President of the Hawaii State Senate, in thanks for the introduction of SB868. This legislation would resolve differing interpretations of Hawaii Revised Statutes regarding prescribing buprenorphine to treat opioid addiction.